Michal Jurášek

561 total citations
39 papers, 453 citations indexed

About

Michal Jurášek is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, Michal Jurášek has authored 39 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Spectroscopy. Recurrent topics in Michal Jurášek's work include Porphyrin and Phthalocyanine Chemistry (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Photodynamic Therapy Research Studies (5 papers). Michal Jurášek is often cited by papers focused on Porphyrin and Phthalocyanine Chemistry (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Photodynamic Therapy Research Studies (5 papers). Michal Jurášek collaborates with scholars based in Czechia, Belarus and United States. Michal Jurášek's co-authors include Silvie Rimpelová, Pavel Drašar, Tomáš Ruml, Jan Tauchen, Eva Kmonı́čková, Marián Hajdúch, Petr Džubák, Vojtěch Spiwok, Jan Škubník and Petr Bartůněk and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Michal Jurášek

36 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Jurášek Czechia 15 219 75 63 58 56 39 453
A. Yu. Misharin Russia 11 211 1.0× 119 1.6× 43 0.7× 49 0.8× 53 0.9× 57 439
Qingjian Dong China 11 165 0.8× 51 0.7× 76 1.2× 69 1.2× 24 0.4× 20 424
Akshaya Murugesan Finland 10 225 1.0× 90 1.2× 31 0.5× 31 0.5× 31 0.6× 35 477
Jing Su China 15 543 2.5× 65 0.9× 68 1.1× 63 1.1× 19 0.3× 47 766
Ying Zheng China 10 247 1.1× 39 0.5× 113 1.8× 51 0.9× 14 0.3× 37 470
Wasundara Fernando Canada 15 382 1.7× 32 0.4× 23 0.4× 58 1.0× 47 0.8× 31 682
Jinfeng Chen China 16 532 2.4× 59 0.8× 97 1.5× 56 1.0× 12 0.2× 27 718
Guojun Pan China 8 204 0.9× 120 1.6× 68 1.1× 36 0.6× 23 0.4× 12 436
Leixiang Yang China 16 340 1.6× 118 1.6× 29 0.5× 20 0.3× 46 0.8× 31 621

Countries citing papers authored by Michal Jurášek

Since Specialization
Citations

This map shows the geographic impact of Michal Jurášek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Jurášek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Jurášek more than expected).

Fields of papers citing papers by Michal Jurášek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Jurášek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Jurášek. The network helps show where Michal Jurášek may publish in the future.

Co-authorship network of co-authors of Michal Jurášek

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Jurášek. A scholar is included among the top collaborators of Michal Jurášek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Jurášek. Michal Jurášek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurášek, Michal, Eduarda Dráberová, Jiřı́ Řehulka, et al.. (2025). Colchicine-BODIPY Probes: Evidence for the Involvement of Intracellular Membranes in the Targeting of Colchicine to Tubulin. ACS Pharmacology & Translational Science. 8(7). 1965–1985.
2.
Tauchen, Jan, et al.. (2025). Synthetic and semi-synthetic antioxidants in medicine and food industry: a review. Frontiers in Pharmacology. 16. 1599816–1599816. 4 indexed citations
3.
Jurášek, Michal, Pavel Drašar, Miloš Petřík, et al.. (2023). Improved syntheses of P2X7 ligands based on substituted benzyl amide of pyroglutamic acid motif labelled with iodine-123 or iodine-125. Journal of Radioanalytical and Nuclear Chemistry. 332(10). 4191–4199.
4.
Jurášek, Michal, et al.. (2022). Let's Create Graphical Abstracts. Chemické listy. 116(2). 99–100. 1 indexed citations
5.
Rumlová, Michaela, Petr Džubák, Jiřı́ Řehulka, et al.. (2021). Betulinic Acid Decorated with Polar Groups and Blue Emitting BODIPY Dye: Synthesis, Cytotoxicity, Cell-Cycle Analysis and Anti-HIV Profiling. Biomedicines. 9(9). 1104–1104. 9 indexed citations
6.
Rimpelová, Silvie, Pavel Drašar, Bohumil Dolenský, et al.. (2021). Steroid Glycosides Hyrcanoside and Deglucohyrcanoside: On Isolation, Structural Identification, and Anticancer Activity. Foods. 10(1). 136–136. 16 indexed citations
7.
Jurášek, Michal, I. Νovotný, Zdeněk Kejík, et al.. (2021). Synthesis and biological evaluation of cationic TopFluor cholesterol analogues. Bioorganic Chemistry. 117. 105410–105410. 6 indexed citations
8.
Pavlíčková, Vladimíra Svobodová, Jan Škubník, Michal Jurášek, & Silvie Rimpelová. (2021). Advances in Purpurin 18 Research: On Cancer Therapy. Applied Sciences. 11(5). 2254–2254. 9 indexed citations
9.
Drašar, Pavel, et al.. (2020). Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin. Biomolecules. 10(12). 1640–1640. 9 indexed citations
10.
Harmatha, Juraj, Miloš Buděšı́nský, Michal Jurášek, et al.. (2019). Structural modification of trilobolide for upgrading its immunobiological properties and reducing its cytotoxic action. Fitoterapia. 134. 88–95. 4 indexed citations
11.
Kuchař, Martin, et al.. (2019). Stanazolol derived ELISA as a sensitive forensic tool for the detection of multiple 17α-methylated anabolics. Steroids. 155. 108550–108550. 7 indexed citations
12.
Pavlíčková, Vladimíra Svobodová, Silvie Rimpelová, Michal Jurášek, et al.. (2019). PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer. Molecules. 24(24). 4477–4477. 16 indexed citations
13.
Rimpelová, Silvie, Michal Jurášek, Vojtěch Spiwok, et al.. (2019). Archangelolide: A sesquiterpene lactone with immunobiological potential from Laserpitium archangelica. Beilstein Journal of Organic Chemistry. 15. 1933–1944. 6 indexed citations
14.
Jurášek, Michal, et al.. (2017). Conjugation of chlorins with spermine enhances phototoxicity to cancer cells in vitro. Journal of Photochemistry and Photobiology B Biology. 168. 175–184. 15 indexed citations
15.
Jurášek, Michal, et al.. (2016). Highly sensitive avidin‐biotin ELISA for detection of nandrolone and testosterone in dietary supplements. Drug Testing and Analysis. 9(4). 553–560. 17 indexed citations
16.
Jurášek, Michal, Miloš Buděšı́nský, M Simková, et al.. (2016). Immunoassay for determination of trilobolide. Steroids. 117. 105–111. 3 indexed citations
17.
Jurášek, Michal, R. P. Litvinovskaya, Darya Straltsova, et al.. (2015). Brassinosteroid-BODIPY conjugates: Design, synthesis, and properties. Steroids. 102. 53–59. 20 indexed citations
18.
Rimpelová, Silvie, Michal Jurášek, Miloš Buděšı́nský, et al.. (2014). Trilobolide–porphyrin conjugates: On synthesis and biological effects evaluation. Steroids. 97. 8–12. 16 indexed citations
19.
Jurášek, Michal, Silvie Rimpelová, Vladimíra Svobodová Pavlíčková, et al.. (2014). Synthesis and biological evaluation of nandrolone–bodipy conjugates. Steroids. 97. 62–66. 12 indexed citations
20.
Jurášek, Michal, Petr Džubák, David Sedlák, et al.. (2013). Preparation, preliminary screening of new types of steroid conjugates and their activities on steroid receptors. Steroids. 78(3). 356–361. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026